SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ('SELLAS’’ or the 'Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...

Australian microbe research is helping improve our understanding of the potential for life in extreme environments, offering ...

For years, scientists have believed that inflammation inevitably increases with age, quietly fuelling diseases like heart ...

Scientists have created an artificial RNA system that can copy itself using simple building blocks and temperature changes.